Deseret Mutual Benefit Administrators Increases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Deseret Mutual Benefit Administrators boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,753 shares of the company’s stock after buying an additional 242 shares during the period. Deseret Mutual Benefit Administrators’ holdings in GE HealthCare Technologies were worth $165,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Pathway Financial Advisers LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth about $25,000. LGT Financial Advisors LLC raised its position in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Fred Alger Management LLC bought a new stake in GE HealthCare Technologies in the second quarter worth about $26,000. Elkhorn Partners Limited Partnership purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $31,000. Finally, ORG Partners LLC grew its stake in shares of GE HealthCare Technologies by 2,475.0% during the second quarter. ORG Partners LLC now owns 412 shares of the company’s stock valued at $32,000 after buying an additional 396 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Up 0.2 %

Shares of NASDAQ:GEHC opened at $86.94 on Thursday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $39.72 billion, a PE ratio of 23.84, a P/E/G ratio of 3.12 and a beta of 1.24. GE HealthCare Technologies Inc. has a 12-month low of $66.39 and a 12-month high of $94.55. The business’s fifty day simple moving average is $88.80 and its 200-day simple moving average is $83.48.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same period in the previous year, the company posted $0.99 earnings per share. The firm’s revenue was up .9% on a year-over-year basis. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.30%.

Analysts Set New Price Targets

A number of research firms recently issued reports on GEHC. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday, September 18th. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Finally, Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.36.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.